Sitotoksik T lenfositleri ve bağışıklık aracılı nörolojik patolojilerde kan-beyin bariyer bütünlüğünün modüle edilmesindeki ikili rolleri.

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

The blood-brain barrier (BBB) is a dynamic, multicellular interface that preserves central nervous system (CNS) homeostasis by restricting entry of pathogens and circulating cells. Cytotoxic T lymphocytes (CTLs), comprising both CD8⁺ and CD4⁺ subsets, are central to adaptive immunity through targeted elimination of infected or transformed cells. However, in immune-mediated neurological disorders, including viral encephalitis, multiple sclerosis, Parkinson’s disease, and glioma, CTLs effector functions can inadvertently compromise BBB integrity. Here, we integrate findings from primary research to delineate three principal mechanisms by which CTLs modulate the BBB: (1) direct cytotoxicity, in which perforin/granzyme release and FasL-Fas interactions induce endothelial cell apoptosis; (2) proinflammatory cytokine signaling, notably IFN‑γ and TNF‑α activation of JAK/STAT and NF‑κB pathways in brain microvascular endothelial cells; and (3) chemokine‑driven leukocyte trafficking, wherein CXCL10 and CCL5 gradients promote CTLs and bystander immune cell migration across the barrier. We further review evidence from in vitro and in vivo models that illustrate both protective and deleterious roles of CTLs at the neurovascular interface. By clearly specifying these mechanisms and their disease‑specific contexts, this review establishes a unified framework for future investigations aimed at preserving BBB function while maintaining effective CTL‑mediated immunity.

İlgili konular